Search

everythinglearnresearchcommunity

for

Search:↓

Taking finasteride before surgery reduces blood loss in prostate procedures.

Alstonia boonei phytochemicals show promise as alternative treatments for BPH with fewer side effects than current drugs.

Purple corn extract may help reduce prostate enlargement and inflammation.

Dutasteride and finasteride have similar effects on prostate cancer risk in BPH patients.

Pterostilbene significantly reduces prostate enlargement and has strong antioxidant effects.

UHP-sCESr is as effective as HESr for treating BPH symptoms.

Most legal cases about 5α-reductase inhibitors, drugs for hair loss and prostate issues, complain about side effects and delayed cancer diagnosis, with most lawsuits settled out of court.

Medications for hair loss and prostate issues can significantly increase the risk of sexual side effects and other negative symptoms.

New treatments targeting fibrosis could improve urinary symptoms in BPH.

The developed model can predict effective 5-alpha-reductase enzyme inhibitors.

Doctors should prescribe cheaper, off-label medication and teach patients how to use it to save money ethically.

5-alpha reductase inhibitors can cause sexual, neurologic, endocrine, and cardiovascular side effects, but these are rare and usually stop after ending treatment.

Using finasteride for hair loss or prostate issues does not significantly raise the risk of erectile dysfunction.

Finasteride treats baldness but may cause lasting sexual side effects.

The saw palmetto extract effectively inhibits an enzyme linked to prostate issues, showing promise for prostate health.

The body's change of testosterone into DHT is not necessary for testosterone's muscle and sexual effects.

Dutasteride is effective for treating prostate enlargement and reducing related surgery risk, but is not approved for preventing prostate cancer.

Scutellaria baicalensis may help treat benign prostatic hyperplasia.

Dutasteride is cheaper than finasteride for treating benign prostatic hyperplasia.

Piper cubeba and Aquilaria sinensis may help prevent or treat prostate issues by balancing hormones.

5α-reductase inhibitors can reduce prostate cancer risk but may increase high-grade tumors, needing more research.

A new compound that could treat various androgen-related conditions was created and analyzed.

Hydroxychloroquine may help treat benign prostatic hyperplasia by reducing inflammation and promoting cell death.

Dutasteride is slightly better than finasteride for treating BPH but has fewer sexual side effects.

Polygenic risk scores can predict the risk and outcomes of benign prostatic hyperplasia.

Finasteride may increase the risk of suicide or severe self-harm in men with mood disorders but not in the general population.

The main prostate diseases in dogs are benign growth, infections, and cancer, with various treatments ranging from drugs to surgery, but cancer treatments have limited success.

5α-reductase inhibitors do not increase anaemia risk compared to α-blockers in men with BPH.

Riboflavin 5′-phosphate (FMN) shows potential for treating androgen-related conditions but may be limited in treating prostate cancer.

Saw palmetto may cause erectile dysfunction and needs better safety monitoring.